Better compliance to antihypertensive medications reduces cardiovascular risk
The DOI matches its Crossref record; 57 of the 59 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The effect of compliance with antihypertensive medications on the risk of cardiovascular outcomes in a population without a known history of cardiovascular disease has been addressed by a large population-based prospective, cohort study carried out by linking Italian administrative databases. METHODS: The cohort of 242 594 patients aged 18 years or older, residents in the Italian Lombardy Region, who were newly treated for hypertension during 2000-2001, was followed from index prescription until 2007. During this period patients who experienced a hospitalization for coronary or cerebrovascular disease were identified (outcome). Exposure to antihypertensive drugs from index prescription until the date of hospitalization or censoring was assessed. Proportional hazards models were fitted to assess the association between persistence on and adherence with antihypertensive drug therapy and outcome. Data were adjusted for several covariates. RESULTS: During an average follow-up of 6 years, 12 016 members of the cohort experienced the outcome. Compared with patients who experienced at least one episode of treatment discontinuation, those who continued treatment had a 37% reduced risk of cardiovascular outcomes (95% confidence interval 34-40%). Compared with patients who had very low drug coverage (proportion of days covered ≤ 25%), those at intermediate (from 51 to 75%) and high coverage (>75%) had risk reductions of 20% (16-24%) and 25% (20-29%), respectively. Similar effects were observed when coronary and cerebrovascular events were considered separately. CONCLUSIONS: In the real life setting, fulfillment compliance with antihypertensive medications is effective in the primary prevention of cardiovascular outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonadherence to antihypertensive treatment affects 10%-80% of hypertensive patients and is one of the key drivers of suboptimal BP control. 75-77”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [77]
In the citing paper
“and it is associated with an increased risk of cardiovascular events [45].”
Citations
Cites
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Self-citationDiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
Selected major risk factors and global and regional burden of disease
Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S., & Murray, C. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11403-6 · Cited by 3,594
Law, M. R., Morris, J. K., & Wald, N. J. (2009) · BMJ · doi:10.1136/bmj.b1665 · Cited by 2,775
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis
Robin DiMatteo, M., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002) · Medical Care · doi:10.1097/00005650-200209000-00009 · Cited by 1,490
Worldwide prevalence of hypertension: a systematic review
Kearney, P. M., Whelton, M., Reynolds, K., Whelton, P. K., & He, J. (2004) · Journal of Hypertension · doi:10.1097/00004872-200401000-00003 · Cited by 1,140
Cited by
Items 101–200 of 365
Peng, X., Wan, L., Yu, B., & Zhang, J. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04538-6 · Cited by 49
ARB-Based Single-Pill Platform to Guide a Practical Therapeutic Approach to Hypertensive Patients
Volpe, M., de la Sierra, A., Kreutz, R. H., Laurent, S., & Manolis, A. J. (2014) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-014-0043-6 · Cited by 33
Insani, W. N., Wei, L., Abdulah, R., Alfian, S. D., Ramadhani, N. A., Andhika, R., Zakiyah, N., Adesuyan, M., Pamela, Y., Mustafa, R., et al. (2024) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-024-01832-9 · Cited by 34
Research strategies in treatment of hypertension: value of retrospective real-life data
Corrao, G., & Mancia, G. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab899 · Cited by 28
Self-citationMahmoudpour, S. H., Asselbergs, F. W., Souverein, P. C., de Boer, A., & der Zee, A. H. M. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13692 · Cited by 31
Coca, A., Sp, W., Camafort, M., López-López, J., & Yang, E. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.04.011 · Cited by 41
Katzmann, J. L., Mahfoud, F., Böhm, M., Schulz, M., & Laufs, U. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s182765 · Cited by 31
Rea, F., Morabito, G., Savaré, L., Pathak, A., Corrao, G., & Mancia, G. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003497 · Cited by 27
“These cut-off values were used because in previous studies on the Lombardy database these adherence levels showed a clear association with a reduction and an increase of CV outcomes and mortality, respectively [6,17].”
BackgroundMethodInfluentialSelf-citationIshida, T., Oh, A., Hiroi, S., Shimasaki, Y., Nishigaki, N., & Tsuchihashi, T. (2018) · Hypertension Research · doi:10.1038/s41440-018-0127-0 · Cited by 28
Adherence to Treatment in Hypertension
Villalva, C. M., Álvarez, X. L. L., Mondelo, T. G., Fachado, A. A., & Cubiella, J. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_77 · Cited by 32
Mancia, G., Coca, A., Chazova, I. E., Girerd, X. J., Haller, H. G., Pauletto, P., Pupek‐Musialik, D., & Svyshchenko, Y. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000239 · Cited by 27
Self-citationBramlage, P., Ketelhut, R. G., Fronk, E., Wolf, W.-P., Smolnik, R., Zemmrich, C., & Schmieder, R. E. (2014) · Clinical Drug Investigation · doi:10.1007/s40261-014-0188-z · Cited by 27
Executive Agency for Health and Consumers
Looper, L. (2014) · European Union regulations | European Encyclopedia of law · Cited by 24
Bonifazi, M., Franchi, M., Rossi, M., Zambelli, A., Moja, L., Zambon, A., Corrao, G., Vecchia, C. L., Zocchetti, C., & Negri, E. (2014) · The Breast · doi:10.1016/j.breast.2014.05.022 · Cited by 26
Self-citationKrousel-Wood, M. A., Peacock, E., Joyce, C., Li, S., Frohlich, E. D., Ré, R. N., Mills, K. T., Chen, J., Stefanescu, A. R., Whelton, P. K., et al. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000001955 · Cited by 24
Campana, É. M. G., Cunha, V. D. S., Glaveckaitė, S., Gruev, I. T., Lamirault, G., Lehmann, E., Masi, S., Kuate, L. M., Mishchenko, L. A., Ona, D. I. D., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002598 · Cited by 27
“Analysis of an Italian cohort of 242 594 patients newly treated for hypertension showed that over a 6-year period, 79% of patients had at least one episode of treatment discontinuation and 48% of patients were classified as having low or very low adherence [23].”
BackgroundOptimal recall period in assessing the adherence to antihypertensive therapy: a pilot study
Doró, P., Benkő, R., Czakó, A., Matúz, M., Thurzó, F., & Soós, G. (2011) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-011-9529-7 · Cited by 23
Tsioufis, K., Δούμα, Σ., Kallistratos, M. S., & Manolis, A. J. (2019) · Clinical Drug Investigation · doi:10.1007/s40261-019-00761-0 · Cited by 23
Corrao, G., Zambon, A., Parodi, A., Merlino, L. G., & Mancia, G. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2011.261 · Cited by 26
Self-citationBlood Pressure Control in Italian Essential Hypertensives Treated by General Practitioners
Giannattasio, C., Cairó, M., Cesana, F., Alloni, M., Sormani, P., Colombo, G., Grassi, G., & Mancia, G. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2012.108 · Cited by 24
Self-citationFerri, C. (2021) · Future Cardiology · doi:10.2217/fca-2021-0048 · Cited by 27
Corrêa, N. B., de Faria, A. P., Ritter, A. M. V., Sabbatini, A. R., Almeida, A. R., Brunelli, V., Calhoun, D. A., Moreno, H., & Modolo, R. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.03.194 · Cited by 26
Visit-to-Visit Blood Pressure Variability
Mancia, G. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07139 · Cited by 21
Self-citationMetoprolol in the treatment of cardiovascular disease: a critical reappraisal
Grassi, G. M. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1479245 · Cited by 22
Nurakysh, S., Kurakbayev, K., Kosherbayeva, L., Tazhiyeva, A. Y., Aimakhanova, A. S., Kulkaeva, G., Asykbaeva, L., Ainabekov, M., Fakhradiyev, I. R., & Tanabayeva, S. B. (2022) · Acta Informatica Medica · doi:10.5455/aim.2022.30.18-24 · Cited by 23
Pobrotyn, P., Pasieczna, A. H., Diakowska, D., Uchmanowicz, B., Mazur, G. J., Banasik, M., & Kołtuniuk, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173771 · Cited by 22
Uncontrolled hypertension in patients with type 2 diabetes: What are the correlates?
Rabizadeh, S., Gholami, B., Kani, S. M., Rajab, A., Farrokhpour, H., Esteghamati, A., & Nakhjavani, M. (2021) · Journal of Clinical Hypertension · doi:10.1111/jch.14352 · Cited by 23
Scotti, L., Baio, G., Merlino, L. G., Cesana, G., Mancia, G., & Corrao, G. (2013) · Value in Health · doi:10.1016/j.jval.2012.11.008 · Cited by 17
Self-citationNikolaev, N., Martynov, A., Skirdenko, Y. P., Anisimov, V. N., Vasilieva, I. A., Vinogradov, O. I., Lazebnik, L. B., Poddubnaya, I. V., Roitman, E. V., & Ageev, F. T. (2020) · Medical news of the North Caucasus · doi:10.14300/mnnc.2020.15109 · Cited by 20
Secondary hypertension as a cause of treatment resistance
Sudano, I., Suter, P. M., & Beuschlein, F. (2023) · Blood Pressure · doi:10.1080/08037051.2023.2224898 · Cited by 27
Triple Combination Therapy for Global Cardiovascular Risk: Atorvastatin, Perindopril, and Amlodipine
Bertrand, M. E., Vlachopoulos, C. V., & Mourad, J. (2016) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0175-2 · Cited by 19
Kurdi, A. B., Chen, L., & Elliott, R. A. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001382 · Cited by 20
“Poor adherence to antihypertensive drugs is associated with increased cardiovascular events and hospitalizations with subsequently high costs and healthcare resources utilization [10,11].”
BackgroundGoyal, A., Jain, H., Verma, A., Jain, J., Shamim, U., Kanagala, S. G., Motwani, J., Dey, R. C., Chunawala, Z. S., Sohail, A. H., et al. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102196 · Cited by 17
Short-Term and Long-Term Blood Pressure Variability
Mancia, G. (2012) · Springer eBooks · doi:10.1007/978-88-470-2601-8_8 · Cited by 16
Self-citationRea, F., Mella, M., Compagnoni, M. M., Cantarutti, A., Merlino, L. G., Mancia, G., & Corrao, G. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002222 · Cited by 17
“The threshold of 75% was chosen because in previous studies on the Lombardy database, this adherence level consistently showed an association with a marked reduction of mortality and cardiovascular outcomes [22,23,27].”
MethodSelf-citationWehland, M., Simonsen, U., Buus, N. H., Krüger, M., & Grimm, D. G. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1735356 · Cited by 17
“drugs may depend on the genotype of the patient [11], but patient adherence to the antihypertensive treatment is a significant factor of importance for success [12].”
BackgroundPallangyo, P., Komba, M., Mkojera, Z., Kisenge, P. R., Bhalia, S. V., Mayala, H. A., Kifai, E., Richard, M. K., Khanbhai, K., Wibonela, S., et al. (2022) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s374674 · Cited by 29
Individualization of Antihypertensive Drug Treatment
Mancia, G., & Grassi, G. M. (2013) · Diabetes Care · doi:10.2337/dcs13-2013 · Cited by 17
Self-citationPersu, A., Lopez‐Sublet, M., Algharably, E. A. E., & Kreutz, R. H. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.12857 · Cited by 19
Alfian, S. D., Annisa, N., Perwitasari, D. A., Coelho, A., & Abdulah, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.985293 · Cited by 30
“The nonadherence to antihypertensive medications is associated with increased risks of resistant hypertension (Hamrahian, 2020), cerebrovascular and coronary events (Corrao et al., 2011), reduced quality of life (Peacock et al.”
BackgroundWays to increase adherence to antihypertensive therapy
Boytsov, S. A., IuA, K., Logunova, N. A., Burtsev, Y., Kvasnikov, B. B., & Владиславовна, Х. Ю. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2022-5202 · Cited by 20
Koikov, V. (2011) · Journal of Health Development · doi:10.32921/2225-9929-2020-2-37-4-19 · Cited by 15
Adherence to cardiovascular prevention strategies in patients with rheumatoid arthritis
der Stoep, D. F. V. B.-V., Zijlmans, J., van Zeben, D., Klop, B., van de Geijn, G., van der Meulen, N., Hazes, M., Birnie, E., & Cabezas, M. C. (2015) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2015.1028997 · Cited by 16
“001 Smoking 15 (14) 3 (10) 2 (10) 10 (17) 0.”
Ledur, P. D. S., Leiria, L. F., Severo, M., Silveira, D. T., Massierer, D., Becker, A. D., Aguiar, F. M., Gus, M., & Schaan, B. D. (2013) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2013.07.006 · Cited by 16
“Exclusion criteria were: body mass index (BMI) > 35 kg/m(2), previously diagnosed chronic illness, arrhythmias (atrial fibrillation) that could interfere with BP measurement, and patients with ABPM records with less than 6 and 18 measures during the night and the day periods, respectively.(18) According to these crite…”
BackgroundÖsterreichischer Blutdruckkonsens 2019
Hypertensiologie, Ö. G. F., Weber, T., Atherosklerosegesellschaft, Ö., Gesellschaft, Ö. D., Angiologie, Ö. G. F. I., Nephrologie, Ö. G. F., Gesellschaft, Ö. K., Neurologie, Ö. G. F., Schlaganfall-Gesellschaft, Ö., Allgemeinmedizin, Ö. G. F., et al. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-01565-0 · Cited by 18
Adherence to antihypertensive drug treatment in Argentina: A multicenter study
Espeche, W. G., Salazar, M. R., Sabio, R., Díaz, A., Sisnieguez, C. E. L., Olano, D., Balbín, E., Renna, N. F., Grosse, P., Flores, R. A., et al. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13830 · Cited by 17
Lauder, L., Ewen, S., Kunz, M., Richter, L. H. J., Jacobs, C. M., Kindermann, I., Böhm, M., Meyer, M. R., & Mahfoud, F. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014180 · Cited by 19
Hypertension in frail older adults: current perspectives
Li, L., Duan, L., Xu, Y., Ruan, H., Zhang, M., Zheng, Y., & He, S. (2024) · PeerJ · doi:10.7717/peerj.17760 · Cited by 30
“Poor adherence to antihypertensive treatment may increase the risk of hypertension-related adverse health outcomes ( Burnier et al., 2013 ; Corrao et al., 2011 ).”
BackgroundAdherence and Health Care Costs with Single-Pill Fixed-Dose Combinations in Hypertension Management
Hilleman, D. E. (2014) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2014.20.1.93 · Cited by 17
Glasser, S. P., Vitolins, M. Z., Rocco, M. V., Still, C. H., Cofield, S. S., Haley, W. E., & Goff, D. C. (2021) · American Journal of Hypertension · doi:10.1093/ajh/hpab145 · Cited by 18
Wang, J., Huang, S. S., Chen, Y., & Zhou, J. (2014) · Patient Preference and Adherence · doi:10.2147/ppa.s66777 · Cited by 14
Wang, A., Wan, J., Zhu, L., Chang, W., Wen, L., Tao, X., & Jin, Y. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1283416 · Cited by 18
“In one study, patients with good medication adherence were 45% more likely to achieve blood pressure control than those with poor adherence (17), and good medication adherence reduced the risk for cardiovascular outcomes by 37% (18).”
BackgroundMancia, G., Schumacher, H., Böhm, M., Mann, J. F. E., Redón, J., Facchetti, R., Schmieder, R. E., Lonn, E., Teo, K. K., & Yusuf, S. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002567 · Cited by 14
“Because of their association with prognosis [30,31], adjustment was extended to nonfatal cardiovascular outcomes and adherence to treatment (pill counting) during the initial two years of treatment as well as to the initial and”
BackgroundSelf-citationAntihypertensive medication adherence and cardiovascular disease risk: A longitudinal cohort study
Li, J., Zhang, Z., Si, S., Wang, B., & Xue, F. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.01.005 · Cited by 17
Trefond, J., Hermet, L., Lambert, C., Vaillant-Roussel, H., Pouchain, D., Ménini, T., Pereira, B., & Vorilhon, P. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01725-8 · Cited by 19
Ciardullo, S., Savaré, L., Rea, F., Perseghin, G., & Corrao, G. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3791 · Cited by 15
“9 The latter aspect is crucial, as the effect of adherence to drugs on hard clinical outcomes in the setting of chronic disorders has been demonstrated for different drug classes such as blood pressure 10 and lipid lowering agents, 11 while evidence is less robust for novel glucose lowering drugs.”
BackgroundSelf-citationAdherence to Triple-Free-Drug Combination Therapies Among Patients With Cardiovascular Disease
Lombardi, N., Crescioli, G., Simonetti, M., Marconi, E., Vannacci, A., Bettiol, A., Parretti, D., Cricelli, C. A., & Lapi, F. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.01.036 · Cited by 12
Bhagavathula, A. S., Shah, S. M. A., & Aburawi, E. H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10215036 · Cited by 15
Tanaka, R., Okawa, M., & Ujike, Y. (2016) · Prehospital and Disaster Medicine · doi:10.1017/s1049023x15005440 · Cited by 12
Kim, C., Do, Y., Kim, B., Lee, K., Nah, M., Kim, U., Lee, J., & Hwang, T. (2021) · Journal of Clinical Hypertension · doi:10.1111/jch.14320 · Cited by 11
Rea, F., Iorio, A., Barbati, G., Bessi, R., Castrichini, M., Nuzzi, V., Scagnetto, A., Senni, M., Corrao, G., Sinagra, G., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.11.018 · Cited by 11
Self-citationRitscher, S., Georges, C. M. G., Wunder, C., Wallemacq, P. E., Persu, A., & Toennes, S. W. (2020) · Blood Pressure · doi:10.1080/08037051.2020.1763775 · Cited by 13
Volpe, M., de la Sierra, A., Ammentorp, B., & Laeis, P. (2014) · Advances in Therapy · doi:10.1007/s12325-014-0117-9 · Cited by 11
“More importantly, analyses have shown that poor adherence is associated with an increased risk of CV events, including coronary events, stroke and heart failure [16–19].”
BackgroundMorabito, G., Gregorio, C., Ieva, F., Barbati, G., Mancia, G., Corrao, G., & Rea, F. (2024) · BMC Public Health · doi:10.1186/s12889-024-19346-4 · Cited by 13
Self-citationGrassi, G. M., Seravalle, G., Brambilla, G., Bombelli, M., Dell’Oro, R., Gronda, E., & Mancia, G. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0312-5 · Cited by 10
Self-citationSimonyi, G., Ferenci, T., Alföldi, S., & Farsang, C. (2016) · Journal of International Medical Research · doi:10.1177/0300060516645004 · Cited by 10
Trivedi, R., Marschner, S. L., Shaw, T. J., Min, H., Yue, J., Kazi, S., Nguyen, T. N., Laranjo, L., & Chow, C. K. (2023) · Heart · doi:10.1136/heartjnl-2023-322602 · Cited by 10
Obstructive Sleep Apnea and Arterial Hypertension: Implications of Treatment Adherence
Posadas, T., Campos‐Rodríguez, F., Sapiña-Beltrán, E., Oscullo, G., Torres, G., & Martínez‐García, M. Á. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-1015-y · Cited by 12
Haung, Z., & Hong, S. A. (2022) · International Health · doi:10.1093/inthealth/ihac047 · Cited by 9
Factors associated with medication adherence among young adults with hypertension
Kim, E., Lee, H., Kim, E.-J., Cho, S. M. J., Kim, H. C., & Lee, H. (2025) · Clinical Hypertension · doi:10.5646/ch.2025.31.e18 · Cited by 12
Jande, M. B., Katabalo, D. M., Sravanam, P., Marwa, C., Madlan, B., Burger, J. R., Godman, B., Oluka, M. N., Massele, A. Y., & Mwita, S. M. (2017) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2016-0060 · Cited by 9
RetractedClinical impact of guideline-based practice and patients’ adherence in uncontrolled hypertension
Sohn, I. S., Kim, C.-J., Yoo, B., Kim, B. J., Choi, J. W., Kim, D., Lee, S., Song, W., Jeon, D. W., Jun, T. Y., et al. (2021) · Clinical Hypertension · doi:10.1186/s40885-021-00183-1 · Cited by 9
Baharvand, P., Malekshahi, F., & Babakhani, A. (2023) · Health Science Reports · doi:10.1002/hsr2.1501 · Cited by 15
Optimizing drug adherence in hypertension: More than a mind game
Robberechts, T., Stoenoiu, M. S., Burnier, M., & Persu, A. (2024) · Kardiologia Polska · doi:10.33963/v.phj.99493 · Cited by 12
Hypertension and Health Behaviors in Females Across the Lifespan
Krousel-Wood, M. A. (2015) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000515 · Cited by 10
Quaschning, K., Koerner, M., & Wirtz, M. A. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-07987-3 · Cited by 11
Corrao, G., Rea, F., Merlino, L. G., Mazzola, P., Annoni, F., & Annoni, G. (2017) · BMC Neurology · doi:10.1186/s12883-017-0796-3 · Cited by 10
Self-citationLiu, H., Teng, S., Lin, X., Shang, Y., Wang, L., Zhang, J., & Zang, Y. (2017) · Chinese Nursing Research · doi:10.1016/j.cnre.2017.03.005 · Cited by 10
Wei, F., Zhang, Z., Huang, Q., Yang, W., & Staessen, J. A. (2018) · Kardiologia Polska · doi:10.5603/kp.a2018.0129 · Cited by 11
Medication adherence and non-adherence in arterial hypertension: a narrative review
Tomasino, C., & Tomasino, M. (2025) · Exploration of Medicine · doi:10.37349/emed.2025.1001276 · Cited by 11
Gikunda, C. N., Gitonga, L. K., & Kamweru, P. K. (2021) · Open Journal of Clinical Diagnostics · doi:10.4236/ojcd.2021.112002 · Cited by 10
Drug Adherence in Hypertension
Burnier, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-15961-4_43 · Cited by 12
Blecker, S., Schoenthaler, A., Martinez, T. R., Belli, H. M., Zhao, Y., Wong, C., Fitchett, C., Bearnot, H. R., & Mann, D. (2023) · JMIR Research Protocols · doi:10.2196/47930 · Cited by 9
Lévy, P., Lemański, T., Crossan, C., Lefebvre, A., Brière, J., Esposti, L. D., & Khan, Z. (2024) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2024.2365988 · Cited by 10
The position of renal denervation in treatment of hypertension: an expert consensus statement
Zeijen, V. J. M., Kroon, A. A., van den Born, B. H., Blankestijn, P. J., Meijvis, S. C. A., Nap, A., Lipsic, E., Elvan, A., Versmissen, J., van Geuns, R., et al. (2022) · Netherlands Heart Journal · doi:10.1007/s12471-022-01717-4 · Cited by 10
Lapi, F., Lucenteforte, E., Moschini, M., Bonaiuti, R., Pirro, M. D., Barchielli, A., Benemei, S., Belladonna, M., Nesti, N., Coppini, R., et al. (2013) · Aging Clinical and Experimental Research · doi:10.1007/s40520-013-0060-7 · Cited by 8
Gikunda, C. N., & Gitonga, L. K. (2019) · Open Journal of Clinical Diagnostics · doi:10.4236/ojcd.2019.93007 · Cited by 10
Agapito, I., Hoang, T., Sayer, M., Naqvi, A., Patel, P. M., & Ozaki, A. F. (2024) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocae203 · Cited by 7
Saito, I., Kushiro, T., Matsushita, Y., Sato, Y., Sagawa, K., Tanaka, Y., Tanigawa, M., & Okutani, Y. (2015) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2015.1047949 · Cited by 7
Kreutz, R. H., Ammentorp, B., Laeis, P., & de la Sierra, A. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12408 · Cited by 8
Wytyczne ESH/ESC dotyczące postępowania w nadciśnieniu tętniczym w 2013 roku
Suplement, K. P. (2013) · Kardiologia Polska · doi:10.5603/kp.2013.0177 · Cited by 18
Evaluating sources of bias in observational studies
Corrao, G., Rea, F., & Mancia, G. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002725 · Cited by 7
Self-citationCurrent Status and Future Perspectives of Renal Denervation
Choi, K. H., & Choi, S. (2021) · Korean Circulation Journal · doi:10.4070/kcj.2021.0175 · Cited by 9
Pocohuanca-Ancco, L., Juan, V., & Hurtado-Roca, Y. (2021) · Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo · doi:10.35434/rcmhnaaa.2021.143.1252 · Cited by 24
Levin, J. B., Moore, D. J., Depp, C. A., Montoya, J. L., Briggs, F. B. S., Rahman, M., Stange, K. C., Einstadter, D., Weise, C., Conroy, C. M., et al. (2022) · Trials · doi:10.1186/s13063-022-06449-9 · Cited by 12
Burnier, M., Redón, J., & Volpe, M. (2023) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-023-00563-8 · Cited by 11
Kobalava, Z. D., Kvasnikov, B. B., Burtsev, Y., & on behalf of the PRIDE study investigators (2023) · Advances in Therapy · doi:10.1007/s12325-023-02462-9 · Cited by 9
Stabile, E., Muiesan, M. L., Ribichini, F. L., Sangiorgi, G., Taddei, S., Versaci, F., Villari, B., Bacca, A., Benedetto, D., Fioretti, V., et al. (2024) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.23.06433-5 · Cited by 7
Non-interventional management of resistant hypertension
Doumas, M. N., Tsioufis, C., Faselis, C., Lazaridis, A., Grassos, H., & Papademetriou, V. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i10.1080 · Cited by 7
Malo, S., Rabanaque, M. J., Orlando, V., Limongelli, G., Feja, C., Aguilar‐Palacio, I., Lallana, M. J., Russo, V., & Menditto, E. (2019) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2019.1567338 · Cited by 7
Metadata
- Authors
- Corrao, G., Parodi, A., Nicotra, F., Zambon, A., Merlino, L., Cesana, G., & Mancia, G.
- Affiliations
- University of Milano-Bicocca (IT)
- University of Milan (IT)
- Regione Lombardia (IT)
- IRCCS Istituto Auxologico Italiano (IT)
- Corresponding author
- Corrao, Giovanni
- Venue
- Journal of Hypertension
- Published
- 2011-03
- Volume
- 29
- Issue
- 3
- Pages
- 610-618
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W1970957826
- Cited by
- 367
- References
- 59
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 33 · 2023: 26 · 2022: 26 · 2021: 35 · 2020: 33 · 2019: 33 · 2018: 29 · 2017: 22 · 2016: 17 · 2015: 18 · 2014: 25 · 2013: 21 · 2012: 10
- FWCI
- 11.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Funders
- Regione Lombardia
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Keywords
- antihypertensive medication adherence, hypertension, cardiovascular risk, cardiovascular hospitalization, coronary disease, cerebrovascular disease, primary prevention, treatment persistence, proportion of days covered
- MeSH terms
- Adult, Aged, Antihypertensive Agents, Cardiovascular Diseases, Female, Humans, Hypertension, Male, Middle Aged, Prospective Studies, Risk, Cohort Studies, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.